本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Reviva Pharmaceuticals Holdings, Inc. Warrant 2025/12/25 11.5C

0.0630
-0.0038-5.69%
成交量:4.28万
成交额:2,277.37
市值:- -
市盈率:- -
高:0.0630
开:0.0572
低:0.0500
收:0.0668
数据加载中...
2023/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2023/01/04

重要事件披露

Form 8-K - Current report
2022/11/14

重要事件披露

Form 8-K - Current report
2022/11/14

重要事件披露

Form 8-K - Current report
2022/11/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2022/10/13

SEC问询函

Form CORRESP - Correspondence
2022/10/06

招股说明书

Form S-1 - General form for registration of securities under the Securities Act of 1933
2022/09/12

超过5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2022/09/07

重要事件披露

Form 8-K - Current report
2022/08/15

重要事件披露

Form 8-K - Current report
2021/06/16

重要事件披露

8-K - Current report
2021/06/14

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超过5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/05/25

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/19

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/17

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/05/10

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/05/10

重要事件披露

8-K - Current report
2021/05/07

重要事件披露

8-K - Current report